| Literature DB >> 17716505 |
B Pandey1, K Shrestha, J Lewis, R A Hawksworth, S L Walker.
Abstract
Dapsone is a component of multi-drug therapy (MDT) for the treatment of all types of leprosy. It is known that dapsone hypersensitivity syndrome (DHS) complicates the treatment in a proportion of patients. We performed a retrospective study of patients commenced on MDT between 1990 and 2006; 2% developed DHS and 0.25% died due to DHS.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17716505 DOI: 10.1258/004947507781524700
Source DB: PubMed Journal: Trop Doct ISSN: 0049-4755 Impact factor: 0.731